FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lexapro (escitalopram) filed by Allergan, Inc. This is a supplemental approval of the NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Lexapro (escitalopram)

Snippet

SUPPL AP for LEXAPRO (ESCITALOPRAM)